Mechanistic experiments showed that gut microbiota activated Toll-like receptor 4 (TLR4), resulting in modulation of tumor-infiltrating immune cells toward a pro-inflammatory, TNF+ phenotype. This evidence concerns the gene TLR4 and neoplasm.